Background: Hematopoietic stem cell and progenitor cell (HSPC)-based genetic therapy to treat HIV or other previously incurable diseases is becoming increasingly realistic. To date, however, our understanding of the regenerative potentials of primate HSPCs lags far behind the level desired for current and future uses of these cells for therapeutic purposes.
Methodology: We report detailed behavior patterns of repopulating HSPCs in four rhesus macaques transplanted for up to 12 years with autologous CD34+ HSPCs engineered with control lentivirus vectors expressing a fluorescence marker (EGFP) or therapeutic vectors expressing shRNA against the HIV-1 co-receptor, C-C chemokine receptor type 5 (CCR5-shRNA). All animals showed normal hematopoietic recovery and maintained stable EGFP marking in all tested blood lineages. In order to study in vivo HSPC behaviors at the single cell level, vector marked clones in serially collected blood were analyzed by large-scale vector integration site (VIS) sequencing and bioinformatics analysis of genomic VIS sequences.
Results: Our long-term clonal tracking study revealed novel mechanistic insights into complex polyclonal hematopoietic reconstitution in primates, not seen in traditional population-based studies. Analysis revealed thousands of HSPC clones successfully engrafted and expanded sequentially over time in each animal, clustered into groups with different kinetics of repopulation, maintaining the total marked blood cells at a relatively stable level over the years. Consistent with recent discoveries in murine HSC studies, the long-term repopulating clones were distinctively grouped into “myeloid-biased”, “lymphoidbiased”, and “balanced” subtypes based on their unique lineage output potentials. Interestingly, clones with more balanced lineage potentials, accounted for only 4 − 10% of the identified clones, yet predominated, contributing up to 25 − 71 % of total repopulating cells in test animals. No notable effect of CCR5-shRNA expression upon clonal repopulation was observed.
Conclusions: This study is the first system level description of the detailed in vivo behavior patterns of primate HSPCs, providing new insights into primate repopulation and a potential frame of reference for future HSPC-based gene-therapies.